EGFR and neoplasm: Treatment of cells showing high EGFR expression was chosen so that the 213Bi-anti-EGFR-MAb could bind to the surface of tumor cells, therefore taking advantage of the high linear energy transfer of the alpha emitter 213Bi13,14.